Delivery Order SPE2DB22D3009-SPE2DB25FAJ00

Award Date 11/6/24
Potential Completion Date 11/7/24
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB24D2010|SPE2DB24FZXB4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $8,389.91 and is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of August 19, 2024. The contract is not designated as a set-aside. Amerisourcebergen, through its Corporate Office...
This federal contract award, identified as SPE2DB20D1109|SPE2DB25FN30T, is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a Firm Fixed Price pricing type, is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $4,076.98 and an ultimate completion date of December 27, 2024. This award is part of...
This federal contract award, SPE2DB24D1104|SPE2DB25FXTM7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,106.18, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMCBJ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,308.65 firm fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of November 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award, SPE2DB22D1017|SPE2DB25FF7LC, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,671.70 firm fixed-price delivery order contract is for TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, and has an ultimate completion date of March 12, 2025. This contract is not associated with any set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award of $7,494.37 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers essential medical...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FRQ48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,122.36 and is a Firm Fixed Price Delivery Order type, with an ultimate completion date of August 28, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, through its Corporate Office Division,...
This federal contract award, with ID SPE2DB24D2101|SPE2DB25FKHRQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,107.71 firm-fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAP84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $18,207.83 and an ultimate completion date of January 29, 2025. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support federal...
This federal contract award, valued at $22,056.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAJ00
    Delivery Order

This federal contract award, with an ID of SPE2DB22D3009|SPE2DB25FAJ00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the procurement of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $30,766.32 and a completion date of November 7, 2024. The contract is a delivery order, with a firm fixed price pricing type. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there are no major subcontractors referenced. The DLA, a defense agency, is the funding agency for this contract, which supports military healthcare programs and the supply of essential medical commodities to federal beneficiaries.

Generated 5/20/25, 2:20 PM